8 completed, 5 active not recruiting, 5 recruiting, 3 unknown. 7 Not applicable, 4 Phase 2, 2 Phase 4, 1 Early Phase 1, 1 Phase 3.
Follow Hypersensitivity Pneumonitis: new trials by email Literature Review of Hypersensitivity Pneumonitis trials Research Report on Hypersensitivity Pneumonitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| "Randomized Controlled Trial Testing the Efficacy of Corticosteroid Therapy Versus Placebo in Fibrotic Hypersensitivity Pneumonitis" Prednisolone, Placebo - Hypersensitivity Pneumonitis | Phase 3 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 120 | 2026-06-01 | 2025-10-07 |
| Occupational and Environmental Exposures Analysis in Interstitial Lung Diseases. standard interview - Interstitial Lung Disease Due to Systemic Disease (Disorder), Interstitial Lung Disease Due to Systemic Disease (Telomere Biology Disorder) | Active not recruiting | Istituto Clinico Humanitas | 1000 | 2026-04-01 | 2026-05-11 | |
| Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis Re-imagining Interventions for Support and Education in Hypersensitivity Pneumonitis (RISE-HP), Staying Well - Hypersensitivity Pneumonitis | Not applicable | Recruiting | Weill Medical College of Cornell University | 42 | 2025-05-06 | 2026-10-16 |
| Skeletal Muscle Function in Interstitial Lung Disease Hyperoxia - Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis | Not applicable | Recruiting | University of British Columbia | 40 | 2024-08-07 | 2026-05-15 |
| A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis AP01, Placebo - Pulmonary Fibrosis, Progressive Pulmonary Fibrosis | Phase 2 | Active not recruiting | Avalyn Pharma Inc. | 398 | 2024-04-03 | 2026-10-16 |
| Contribution of the Indoor Environment Medical Advisor in the Management of Fibrosing Hypersensitivity Pneumonitis Hypersensitivity Pneumonitis | Recruiting | Nantes University Hospital | 100 | 2023-11-16 | 2026-10-16 | |
| Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases Breath test using the Compact PTR-TOF-MS, Portable cardiac monitor "CardioQvark", Assessment of arterial stiffness using the VaSera VS-1500N - Chronic Respiratory Diseases, Cystic Fibrosis | Enrolling by invitation | I.M. Sechenov First Moscow State Medical University | 400 | 2023-01-30 | 2024-07-30 | |
| An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis Mycophenolate Mofetil plus prednisolone, Prednisolone - Hypersensitivity Pneumonitis | Phase 4 | Active not recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 144 | 2022-11-23 | 2026-06-03 |
| Prognostic Score Comparison in IPF and HP GAP Index, ILD-GAP Index, Composite Physiologic Index (CPI) - IPF, Fibrotic Lung Disease | Completed | Saglik Bilimleri Universitesi | 143 | 2022-10-01 | 2025-09-11 | |
| Database and Biobank of Patients With Hypersensitivity Pneumonitis Hypersensitivity Pneumonitis | Recruiting | Nils Hoyer | 50 | 2022-09-18 | 2023-12-22 | |
| HypErsensitiVity PneumonITis: DiseAse Progression Characterization Disease assessment - Hypersensitivity Pneumonitis | Unknown | Hospital do Coracao | 150 | 2022-06-20 | 2023-06-29 | |
| 129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study Hyperpolarized Xe129 - Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis | Phase 2 | Withdrawn | University of Kansas Medical Center | 2022-05-01 | 2022-09-10 | |
| FAPI PET for Lung Fibrosis 68Ga-FAPi-46, Computed Tomography, Positron Emission Tomography - Interstitial Lung Disease, Idiopathic Interstitial Pneumonias | Early Phase 1 | Active not recruiting | University of California, Los Angeles | 30 | 2021-11-16 | 2026-08-20 |
| Interstitial Lung Disease Research Unit Biobank Interstitial Lung Disease, Sarcoidosis | Recruiting | University of Kansas Medical Center | 1000 | 2021-08-09 | 2026-07-10 | |
| Study of Nasal Mucosa Histopathological Changes in Chronic Hypersensitivity Pneumonitis nasal endoscopy - Hypersensitivity Pneumonitis, Nasal Mucosal Disorder | Not applicable | Completed | Cairo University | 40 | 2021-07-01 | 2023-02-13 |
| Pulmonary Rehabilitation in Patients With Chronic Fibrotic Hypersensitivity Pneumonitis Pulmonary Rehabilitation, Alternative Exercises - Hypersensitivity Pneumonitis, Extrinsic Allergic Alveolitis | Not applicable | Unknown | Gazi University | 30 | 2021-06-01 | 2020-09-23 |
| A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis Hypersensitivity Pneumonitis | Active not recruiting | National Jewish Health | 137 | 2021-01-06 | 2026-04-09 | |
| Assessing Health Related Quality of Life in Hypersensitivity Pneumonitis Chronic Hypersensitivity Pneumonitis Health Related Quality of Life Survey Instrument - Hypersensitivity Pneumonitis, Chronic Hypersensitivity Pneumonitis | Completed | Weill Medical College of Cornell University | 60 | 2020-07-10 | 2023-07-27 | |
| This Study Aim is to Compare the Effect of Oral Methyl Prednisolone on Different Radiological Patterns of Hypersensitivity Pneumonitis as it Was Found That Not All Patients Get Satisfying Therapeutic Effect After Taking Corticosteroids. Methyl Prednisolonate - Hypersensitivity Pneumonitis | Phase 4 | Unknown | Al-Azhar University | 110 | 2020-07-01 | 2020-05-26 |
| Evaluation of the Efficacy of Pirfenidone in Progressive Chronic Hypersensitivity Pneumonitis Oral pirfenidone, Standard care - Hypersensitivity Pneumonitis | Phase 2 | Completed | Zagazig University | 40 | 2019-12-01 | 2020-12-19 |
Showing 20 of 26. Sign in to see all of them.
Alveolitis, Extrinsic Allergic (26) · Lung Diseases, Interstitial (11) · Idiopathic Pulmonary Fibrosis (6) · Pulmonary Fibrosis (4) · Idiopathic Interstitial Pneumonias (2) · Sarcoidosis (2) · Asthma (1) · Cardiovascular Diseases (1) · Connective Tissue Diseases (1) · Cystic Fibrosis (1) · Disease (1) · Hypertension, Pulmonary (1) · Lymphangioleiomyomatosis (1) · Motor Activity (1) · Pneumoconiosis (1)
Hypersensitivity (26) · Hypersensitivity, Immediate (26) · Immune System Diseases (26) · Lung Diseases (26) · Respiratory Hypersensitivity (26) · Respiratory Tract Diseases (26) · Lung Diseases, Interstitial (15) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Pulmonary Fibrosis (5) · Fibrosis (4) · Hemic and Lymphatic Diseases (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Hypersensitivity, Delayed (2)
Blood Specimen Collection (3) · Prednisolone (3) · Albuterol (1) · Bronchoscopy (1) · Educational Status (1) · FAPI-46 (1) · Genome (1) · Magnetic Resonance Spectroscopy (1) · Methods (1) · Methylprednisolone (1) · Mycophenolic Acid (1) · Palliative Care (1) · Respiratory Physiological Phenomena (1) · Standard of Care (1) · Therapeutic Irrigation (1)
Cairo University (2) · University of Kansas Medical Center (2) · Weill Medical College of Cornell University (2) · Al-Azhar University (1) · Assistance Publique - Hôpitaux de Paris (1) · Avalyn Pharma Inc. (1) · Centre Hospitalier Universitaire de Besancon (1) · Gazi University (1) · Hospital do Coracao (1) · I.M. Sechenov First Moscow State Medical University (1) · Istituto Clinico Humanitas (1) · Matthias Griese (1) · Nabeel Hamzeh (1) · Nantes University Hospital (1) · National Jewish Health (1)
United States (8) · Egypt (4) · France (3) · Argentina (2) · Brazil (2) · Canada (2) · Germany (2) · Italy (2) · Turkey (Türkiye) (2) · Australia (1) · Belgium (1) · Chile (1) · Denmark (1) · India (1) · Netherlands (1)
Kerri I Aronson, MD (2) · Francesco Amati, MD (1) · Imre Noth, MD (1) · Jeremie Calais, MD (1) · Jordan A Guenette, PhD (1) · Leticia Kawano Dourado, MD (1) · Matthias Griese, Prof., MD (1) · Meike Hengst, MD (1)
PMID 12842854, PMID 1414806, PMID 16166619, PMID 18096541, PMID 20822994, PMID 3371127, PMID 34048641, PMID 36759788, PMID 36948586, PMID 37258647, PMID 39362770, PMID 41448793, PMID 7676971
2025 (1), K23HL163394 (1)